Delivery Order SPE2DB25D3404-SPE2DB26FULYY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a ceiling value of $1,303.03 under a firm fixed-price arrangement. The delivery order carries an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, consistent with the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.45 to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an injectable antibiotic commonly used in military and federal healthcare systems. The award utilizes firm fixed pricing and carries an ultimate completion date of October 16, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $11,342.44 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive set-aside award. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,328.85 to supply Ceftriaxone 1 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. This non-competitive delivery order was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, under a firm fixed price arrangement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a ceiling value of $3,844.78. This non-competitive, firm fixed-price delivery order is set to be completed by November 14, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The order will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used broad-spectrum antibiotic. The contract, valued at $5,210.50 with a firm fixed-price structure, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $1,498.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.38 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $7,765.88. This non-competitive delivery order, issued on September 9, 2025, represents a firm fixed-price pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULYYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,871.80 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. Awarded on November 5, 2025, with completion targeted for November 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a primary pharmaceutical vendor for the Defense Health Agency and federal military healthcare systems, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to fulfill critical medical supply needs across multiple therapeutic domains. The company's extensive portfolio of federal contracts demonstrates its established capability to meet federal medical procurement requirements through competitive procurement processes, supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/5/25 |